To determine whether DNA methylation alterations in the DMRs of Mst1r, Slpi, and Extl1 are involved in the expression of these genes, we assessed the effects of the DNA methylation inhibitor 5-aza-dC on the DNA methylation statuses and gene expressions in mouse liver cancer cell lines (Fig. 5). This evidence concerns the gene SLPI and liver cancer.